Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Hits Price Target Forecast with 27.35% Profit: QuantWave Analysis

May 03, 2023
On February 7, 2023, QuantWave, the automated forecasting platform, issued a long signal for ELI LILLY AND COMPANY with a price target forecast of $423.98. The stock was trading at $332.92 at the time of the signal. On May 3, 2023, ELI LILLY AND COMPANY reached the forecasted price, yielding a profit of 27.35% for investors who followed the recommendation.

This achievement showcases the accuracy and effectiveness of QuantWave's analytics in predicting stock movements. The successful forecast for ELI LILLY AND COMPANY is a testament to the platform's ability to provide valuable insights for traders and investors.

In the broader context of QuantWave's analytics, this forecast success highlights the platform's potential to generate significant profits for users. QuantWave offers predictions for a wide range of stocks, presenting opportunities for individuals to capitalize on market trends and optimize their investment strategies.

For users seeking to enhance their understanding of QuantWave's forecasting system, QuantSchool provides educational resources on professional investment frameworks. By exploring QuantSchool, individuals can learn the key principles for generating consistent income using the QuantWave platform.

Overall, the achievement of the price target forecast for ELI LILLY AND COMPANY underscores the effectiveness of QuantWave's analytics in identifying profitable trading opportunities and maximizing investment returns.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYJuly 20, 2025Strong Q2 Forecast for ELI LILLY AND COMPANY by J.P. Morgan  ~1 min.

According to J.P. Morgan, Eli Lilly and Company is expected to have a strong second quarter performance. The pharmaceutical giant has been receiving positive attention from investors and analysts alike....

LLYMarch 22, 2025Eli Lilly and Company LLY: Leading the Way in Pharmaceutical Innovation  ~2 min.

Eli Lilly and Company (LLY) continues to make waves in the pharmaceutical industry with its innovative and groundbreaking therapies....

LLYMarch 19, 2025Eli Lilly and Company LLY Surges After Breakthrough BRAVE-AA-PEDS Study Results  ~2 min.

Eli Lilly and Company (LLY) has recently made a significant breakthrough in its BRAVE-AA-PEDS study, resulting in a surge of investor attention and market gains....

LLYMarch 18, 2025Eli Lilly and Company: A Promising Investment in the Pharma Industry  ~1 min.

Eli Lilly and Company (LLY) has been making waves in the pharmaceutical industry with its innovative products and strong performance....

LLYMarch 17, 2025Eli Lilly and Company's Groundbreaking Discovery Revolutionizes Pharma Industry  ~2 min.

Eli Lilly and Company, a renowned pharmaceutical giant, has recently made a groundbreaking discovery that is set to revolutionize the entire industry....

LLYMarch 16, 2025Is Eli Lilly and Company LLY Set to Revolutionize the Pharma Industry?  ~2 min.

Eli Lilly and Company (LLY) has been making headlines recently with its groundbreaking research and innovative products....

LLYMarch 14, 2025Eli Lilly and Company Reports Promising Results in Hair Regrowth Study  ~1 min.

Eli Lilly and Company (LLY) recently announced the positive outcome of their Phase 3 clinical trial for baricitinib, a drug aimed at treating severe alopecia areata in adolescents....

LLYFebruary 28, 2025Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding 50 billion  ~1 min.

Eli Lilly and Company (LLY) is set to significantly increase its manufacturing investment in the United States, surpassing a staggering 50 billion since 2020....

LLYFebruary 27, 2025Eli Lilly and Company Acquires Organovos FXR Program in IBD Treatment Development  ~1 min.

Eli Lilly and Company has recently made headlines with its acquisition of Organovos FXR Program, a significant step towards advancing treatment options for Inflammatory Bowel Disease (IBD)....

LLYFebruary 26, 2025ELI LILLY AND COMPANY Launches Additional Zepbound Vial Doses and Offers New Savings  ~2 min.

ELI LILLY AND COMPANY has recently announced the launch of additional Zepbound vial doses, as well as new savings for self-pay patients....

CSCOJune 24, 2025QuantWave Achieves 16.23% Profit Target for CISCO SYSTEMS, INC. Stock Forecast  ~1 min.

QuantWave, an automated forecasting platform, recently celebrated a successful forecast for CISCO SYSTEMS, INC. stock, hitting a profit target of 16.23%....

DOWApril 3, 2025QuantWave Hits Bullseye with DOW INC. Stock Forecast, Generating 17.05% Profit  ~2 min.

QuantWave, a leading automated forecasting platform, has once again showcased its prowess in predicting stock movements with remarkable accuracy....

EOGJuly 15, 2024EOG Resources, Inc. Hits Price Target Forecast with 5.66% Profit: A Success Story for QuantWave  ~2 min.

EOG Resources, Inc. (EOG) investors recently celebrated as the stock hit a price target forecast with a profitable outcome of 5.66%. The forecast signal date was on June 25th, 2024, with a price of $121....

AMZNDecember 5, 2024AMAZON.COM, INC. Hits Price Target Forecast with 16.84% Profit: A Success Story for QuantWave's Analytics  ~1 min.

On May 7, 2024, QuantWave, the automated forecasting platform, issued a long signal for the stock of AMAZON.COM, INC., with a price of 188.76 $....

MADecember 13, 2023MASTERCARD INCORPORATED Hits Price Target Forecast with 20.31% Profit: QuantWave's Success Unveiled  ~2 min.

On January 4th, 2023, QuantWave, the automated forecasting platform, issued a long signal for MASTERCARD INCORPORATED's stock, which was trading at $349.89....